254 related articles for article (PubMed ID: 14689377)
1. HTLV-I/II prevalence in different geographic locations.
Vrielink H; Reesink HW
Transfus Med Rev; 2004 Jan; 18(1):46-57. PubMed ID: 14689377
[TBL] [Abstract][Full Text] [Related]
2. Human T-lymphotropic virus type II and neurological disease.
Araujo A; Hall WW
Ann Neurol; 2004 Jul; 56(1):10-9. PubMed ID: 15236397
[TBL] [Abstract][Full Text] [Related]
3. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
4. The epidemiology and disease outcomes of human T-lymphotropic virus type II.
Roucoux DF; Murphy EL
AIDS Rev; 2004; 6(3):144-54. PubMed ID: 15595431
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of human T-lymphotropic virus infection among blood donors in southeast China, 2004-2013.
Xie J; Ge S; Zhang Y; Lin Y; Ni H; Zhang J; Chen C
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003685. PubMed ID: 25830656
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and biological epidemiology of onco-retroviral HTLV-I and II infections].
De Thé G
Bull Acad Natl Med; 1991; 175(6):861-9; discussion 869-70. PubMed ID: 1742624
[TBL] [Abstract][Full Text] [Related]
8. [Seroprevalence of HTLV-1/2 in blood donors from Misiones Province].
Malan R; Berini CA; Eirin ME; Delfino CM; Pedrozo W; Krupp R; García Plichta A; Biglione MM
Medicina (B Aires); 2010; 70(1):71-4. PubMed ID: 20228028
[TBL] [Abstract][Full Text] [Related]
9. Seroepidemiology of HTLV-I/II in Argentina: an overview.
Gastaldello R; Hall WW; Gallego S
J Acquir Immune Defic Syndr; 2004 Mar; 35(3):301-8. PubMed ID: 15076246
[TBL] [Abstract][Full Text] [Related]
10. [Human T-lymphotropic virus I/II detection in Chilean patients from Sexually Transmitted Diseases clinics].
Sanhueza D; Ramírez E; Navarrete N; Santander E; Garmendia ML; Martínez MJ
Rev Med Chil; 2012 Oct; 140(10):1239-44. PubMed ID: 23559279
[TBL] [Abstract][Full Text] [Related]
11. [Human T-lymphotrophic virus type I and II--diagnosis and clinical presentation].
Christiansen CB
Ugeskr Laeger; 1994 Dec; 156(51):7663-7. PubMed ID: 7839528
[TBL] [Abstract][Full Text] [Related]
12. Human T cell lymphotropic viruses (HTLV-I/II) in South America: should it be a public health concern?
Carneiro-Proietti AB; Catalan-Soares B; Proietti FA;
J Biomed Sci; 2002; 9(6 Pt 2):587-95. PubMed ID: 12432224
[TBL] [Abstract][Full Text] [Related]
13. Human retroviruses.
Weber T; Hunsmann G; Stevens W; Fleming AF
Baillieres Clin Haematol; 1992 Apr; 5(2):273-314. PubMed ID: 1324749
[TBL] [Abstract][Full Text] [Related]
14. Relation between human T-lymphotropic virus type I and neurologic diseases in Panama: 1985-1990.
Gracia F; Castillo LC; Larreategui M; Roberts B; Cedeño V; Heneine W; Blattner W; Kaplan JE; Levine PH
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):192-7. PubMed ID: 7552485
[TBL] [Abstract][Full Text] [Related]
15. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of human T-lymphotropic virus type 1 & 2 (HTLV-1/2) in South African blood donors.
Vermeulen M; Sykes W; Coleman C; Custer B; Jacobs G; Jaza J; Kaidarova Z; Hlela C; Gessain A; Cassar O; Poole C; Ingram C; Murphy EL; Reddy R
Vox Sang; 2019 Jul; 114(5):451-458. PubMed ID: 30950074
[TBL] [Abstract][Full Text] [Related]
17. Vertical transmission of HTLV-I/II: a review.
Bittencourt AL
Rev Inst Med Trop Sao Paulo; 1998; 40(4):245-51. PubMed ID: 9876439
[TBL] [Abstract][Full Text] [Related]
18. Global epidemiology of HTLV-I infection and associated diseases.
Proietti FA; Carneiro-Proietti AB; Catalan-Soares BC; Murphy EL
Oncogene; 2005 Sep; 24(39):6058-68. PubMed ID: 16155612
[TBL] [Abstract][Full Text] [Related]
19. Tropical spastic paraparesis/HTLV-I-associated myelopathy in Europe and in Africa: clinical and epidemiologic aspects.
Touzé E; Gessain A; Lyon-Caen O; Gout O
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S38-45. PubMed ID: 8797702
[TBL] [Abstract][Full Text] [Related]
20. HTLV in the Americas: challenges and perspectives.
Carneiro-Proietti AB; Catalan-Soares BC; Castro-Costa CM; Murphy EL; Sabino EC; Hisada M; Galvão-Castro B; Alcantara LC; Remondegui C; Verdonck K; Proietti FA
Rev Panam Salud Publica; 2006 Jan; 19(1):44-53. PubMed ID: 16536938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
